The arms race over the next generation of obesity drugs is continuing to heat up.
Wegovy, the popular obesity treatment, also seems to offer heart health benefits. On Tuesday, Novo Nordisk reported the results of a comprehensive clinical trial evaluating the drug’s efficacy in preventing heart attacks and strokes in overweight or obese individuals. According to the company, Wegovy cut the risk of…
The makers of two popular but off-label weight loss drugs are now being sued over complications allegedly linked to their use. This week, a Louisiana woman filed a complaint against the companies Novo Nordisk and Eli Lilly, arguing that they have misled patients about the risk of severe gastrointestinal side effects…
UK regulators are investigating the Ozempic and Saxenda weight loss drugs over reports that patients experienced suicidal and self-harming thoughts while taking the medications. The drugs skyrocketed in popularity in the U.S. as doctors began prescribing them to people who struggled with obesity, but new reports are…
Insider
Insider
Robyn Phelps/Insider